|
US1014372A
(en)
|
1910-12-01 |
1912-01-09 |
Bush Mfg Company |
Hinge.
|
|
US1013068A
(en)
|
1911-09-09 |
1911-12-26 |
Frederick F Mcintosh |
Single-trigger gun mechanism.
|
|
US2643653A
(en)
|
1951-07-19 |
1953-06-30 |
Heidrich John |
Pill injector
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
FR2504010B1
(fr)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
DE3377484D1
(en)
|
1982-04-19 |
1988-09-01 |
Nissan Motor |
Method for controlling reduction ratio of continuously variable transmission with acceleration compensation
|
|
US5272065A
(en)
|
1983-10-20 |
1993-12-21 |
Research Foundation Of State University Of New York |
Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
|
|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US6022950A
(en)
|
1984-06-07 |
2000-02-08 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
EP0188256B1
(en)
|
1985-01-14 |
1991-08-21 |
NeoRx |
Metal radionuclide labeled proteins for diagnosis and therapy
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
US6051405A
(en)
|
1986-09-24 |
2000-04-18 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Constructs encoding recombinant antibody-toxin fusion proteins
|
|
US4892827A
(en)
|
1986-09-24 |
1990-01-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
|
|
US5807832A
(en)
|
1987-06-09 |
1998-09-15 |
Biotech Australia Pty Limited |
Oral delivery of biologically active substances bound to vitamin B12
|
|
US5997856A
(en)
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
|
US6780613B1
(en)
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
|
DE69131449T2
(de)
|
1990-05-11 |
1999-11-25 |
The United States Of America, Represented By The Secretary |
Verbesserte exotoxine aus pseudomonas mit geringer toxität bei tieren und hoher zelltötender aktivität
|
|
GB9112553D0
(en)
|
1991-06-11 |
1991-07-31 |
Wellcome Found |
Fusion proteins
|
|
WO1993000077A1
(en)
|
1991-06-21 |
1993-01-07 |
University Of Cincinnati |
Orally administrable therapeutic proteins and method of making
|
|
US6613332B1
(en)
|
1991-06-21 |
2003-09-02 |
The University Of Cincinnati |
Oral administration of therapeutic proteins
|
|
US5487994A
(en)
*
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
WO1993025690A1
(en)
|
1992-06-18 |
1993-12-23 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant pseudomonas exotoxin with increased activity
|
|
PT682524E
(pt)
|
1993-02-02 |
2002-03-28 |
Xoma Technology Ltd |
Composicoes farmaceuticas que contem a proteina bactericida indutora da permeabilidade e um agente tensioactivo
|
|
GB9401787D0
(en)
|
1994-01-31 |
1994-03-23 |
Medeva Holdings Bv |
Vaccine compositions
|
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
|
GB9420355D0
(en)
|
1994-10-10 |
1994-11-23 |
Univ Nottingham |
Preparation of protein microspheres, films and coatings
|
|
US5656730A
(en)
|
1995-04-07 |
1997-08-12 |
Enzon, Inc. |
Stabilized monomeric protein compositions
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US5922680A
(en)
|
1996-10-23 |
1999-07-13 |
Ferring, B.V. |
Stabilized composition for oral administration of peptides
|
|
DE69838667T2
(de)
|
1997-08-01 |
2008-10-30 |
Toray Industries, Inc. |
Verfahren zur stabilisierung nützlicher proteine und nützliche proteinhaltige mittel
|
|
US6342611B1
(en)
|
1997-10-10 |
2002-01-29 |
Cytovia, Inc. |
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
|
|
US6251392B1
(en)
|
1997-10-20 |
2001-06-26 |
Epicyte Pharmaceuticals, Inc. |
Epithelial cell targeting agent
|
|
US6592847B1
(en)
|
1998-05-14 |
2003-07-15 |
The General Hospital Corporation |
Intramolecularly-quenched near infrared flourescent probes
|
|
US7053200B1
(en)
|
1999-06-01 |
2006-05-30 |
Baylor College Of Medicine |
Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
|
|
DE60031999T2
(de)
|
1999-10-04 |
2007-06-06 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Stabilisierte flüssige polypeptid-haltige pharmazeutische zusammensetzungen
|
|
US20030186386A1
(en)
*
|
2000-02-11 |
2003-10-02 |
Hansen Christian Karsten |
Interleukin 10
|
|
ATE442858T1
(de)
|
2000-11-27 |
2009-10-15 |
Powderject Vaccines Inc |
Nukleinsäureadjuvantien
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
DK1450855T3
(da)
|
2001-05-23 |
2010-01-11 |
Duotol Ab |
Undertrykkelse af allergiske reaktioner ved hjælp af transdermal indgivelse af allergener i forbindelse med eller konjugeret til toxin-underenheder eller fragmenter deraf
|
|
JP4623625B2
(ja)
|
2003-07-24 |
2011-02-02 |
株式会社AMBiS |
ヘテロ型５量体組換えワクチン
|
|
EP1522585A1
(en)
|
2003-10-09 |
2005-04-13 |
Plant Research International B.V. |
Chimeric carrier molecules for the production of mucosal vaccines
|
|
AR046960A1
(es)
*
|
2003-12-17 |
2006-01-04 |
Wyeth Corp |
Metodos para producir los conjugados portadores de peptidos inmunogenicos
|
|
US20080317761A1
(en)
|
2004-04-28 |
2008-12-25 |
The Trustees Of The University Of Pennsylvania |
Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage
|
|
US20050281885A1
(en)
|
2004-06-21 |
2005-12-22 |
Egilmez Nejat K |
Method for treating inflammatory bowel disease by oral administration of IL-10
|
|
US7713737B2
(en)
|
2004-10-04 |
2010-05-11 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of macromolecules
|
|
US20090155297A1
(en)
|
2004-10-04 |
2009-06-18 |
Trinity Biosystems, Inc. |
Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
AU2006275865B2
(en)
|
2005-07-29 |
2012-06-28 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH |
Mutated Pseudomonas exotoxins with reduced antigenicity
|
|
CA2631981A1
(en)
|
2005-12-05 |
2007-06-14 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of binding partners
|
|
CA2647168A1
(en)
|
2006-03-16 |
2007-09-27 |
Trinity Biosystems, Inc. |
Methods for increasing the size of animals using needleless delivery constructs
|
|
US8993295B2
(en)
|
2006-07-20 |
2015-03-31 |
The General Hospital Corporation |
Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
|
|
US20090092660A1
(en)
|
2006-08-09 |
2009-04-09 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of particles
|
|
US20100196277A1
(en)
|
2006-10-09 |
2010-08-05 |
The University Of North Carolina At Chapel Hill |
Nanoparticle compositions for controlled delivery of nucleic acids
|
|
WO2008147526A1
(en)
|
2007-05-23 |
2008-12-04 |
The Trustees Of The University Of Pennsylvania |
Targeted carriers for intracellular drug delivery
|
|
WO2009014650A2
(en)
*
|
2007-07-20 |
2009-01-29 |
The General Hospital Corporation |
Recombinant vibrio cholerae exotoxins
|
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗脂肪肝中的应用
|
|
WO2009026328A2
(en)
|
2007-08-21 |
2009-02-26 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
JP5670875B2
(ja)
|
2008-03-17 |
2015-02-18 |
ウニベルジテーツクリニクム ミュンスター |
カーゴ分子の送達ビヒクルおよび炎症反応を免疫調節するための生物学的治療剤としてのＹｏｐＭ
|
|
WO2009149281A1
(en)
|
2008-06-04 |
2009-12-10 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotoxins and uses thereof
|
|
NZ592420A
(en)
|
2008-10-02 |
2012-12-21 |
Emergent Product Dev Seattle |
Cd86 antagonist multi-target binding proteins
|
|
US20120258104A1
(en)
|
2009-07-22 |
2012-10-11 |
Cenix Bioscience Gmbh |
Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes
|
|
WO2011031441A1
(en)
|
2009-08-28 |
2011-03-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Therapy with a chimeric molecule and a pro-apoptotic agent
|
|
US11246915B2
(en)
*
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
|
EP2616045B1
(en)
|
2010-09-15 |
2017-10-25 |
Randall J. Mrsny |
Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
|
|
CA2825023A1
(en)
|
2011-01-26 |
2012-08-02 |
Cenix Bioscience Gmbh |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
WO2012110596A1
(en)
|
2011-02-16 |
2012-08-23 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Fusion protein for the treatment of immunologic or allergic reactions
|
|
ES2773115T3
(es)
|
2011-06-29 |
2020-07-09 |
Rani Therapeutics Llc |
Preparados de agentes terapéuticos para la administración hacia el interior de una luz del tubo intestinal utilizando un dispositivo tragable para la administración de fármacos
|
|
US20160068583A1
(en)
|
2013-04-24 |
2016-03-10 |
Armo Biosciences, Inc. |
Interleukin-10 Compositions and Uses Thereof
|
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术（上海）有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
|
WO2015070077A1
(en)
|
2013-11-07 |
2015-05-14 |
Memorial Sloan-Kettering Cancer Center |
Methods of use for il-22 in the treatment of gastrointestinal graft vs. host disease
|
|
CN111909278B
(zh)
|
2014-01-27 |
2024-04-09 |
分子模板公司 |
Mhc i类表位递送多肽
|
|
PL3139965T3
(pl)
|
2014-05-07 |
2022-01-31 |
Applied Molecular Transport Inc. |
Cząsteczki fuzyjne pochodzące z toksyny cholix do doustnego dostarczania ładunku biologicznie czynnego
|
|
AU2015336101A1
(en)
|
2014-10-22 |
2017-04-20 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
WO2016146833A1
(en)
|
2015-03-19 |
2016-09-22 |
F. Hoffmann-La Roche Ag |
Biomarkers for nad(+)-diphthamide adp ribosyltransferase resistance
|
|
US12241053B2
(en)
|
2015-10-09 |
2025-03-04 |
The Brigham And Women's Hospital, Inc. |
Modulation of novel immune checkpoint targets
|
|
JP2019505511A
(ja)
|
2016-01-06 |
2019-02-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． |
悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法
|
|
EP3192805A1
(en)
|
2016-01-15 |
2017-07-19 |
Humanitas Mirasole S.p.A. |
Inhibitors of t cell activation or stimulation and uses thereof
|
|
US11110122B2
(en)
|
2016-06-03 |
2021-09-07 |
New York University |
Methods and reagents for modulating macrophage phenotype
|
|
JP7084881B2
(ja)
|
2016-06-22 |
2022-06-15 |
アルカームス インコーポレーテッド |
Ｉｌ－１０の免疫刺激特性および抗炎症特性を調節するための組成物および方法
|
|
CA3045310A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
EP3554346B1
(en)
|
2016-12-14 |
2024-01-31 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with an immunosuppressant
|
|
EP3600414A1
(en)
|
2017-03-30 |
2020-02-05 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
|
|
AU2019230230B2
(en)
|
2018-03-08 |
2025-04-10 |
Applied Molecular Transport Inc. |
Toxin-derived delivery constructs for oral delivery
|
|
SG11202104734YA
(en)
|
2018-11-07 |
2021-06-29 |
Applied Molecular Transport Inc |
Cholix-derived carriers for oral delivery of heterologous payload
|